Rapid Detection of Mycobacterium Tuberculosis Complex with IS6110 Marker Based on Real Time PCR High Resolution Melting Analysis.

Multimodality imaging has made great strides in the imaging evaluation of patients with a variety of diseases. Positron emission tomography/magnetic resonance imaging (PET/MRI) is recently been established onto the market after several years of research and has high potential due to offer functional, morphologic and molecular information at the same session. The simple notion of combining the molecular capabilities of the PET and its difference available radiotracers with the excellent tissue resolution of the MRI and wide range of multiparametric imaging techniques has generated great expectations upon the possible uses of this technology. PET/MRI combines the unique features of MRI including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MRI spectroscopy with the quantitative physiologic information that is provided by PET. The current data show that particular applications demanding multiparametric imaging capabilities, high soft tissue contrast and/or lower radiation dose seem to benefit from this novel hybrid modality and could open new horizon to PET/MRI. The lower radiation dose compared to PET/com¬puted tomography will be particularly valuable in the imag¬ing of young patients with potentially curable diseases. Furthermore, integrated PET/MRI appears to have added value in onco¬logic applications and also have potential benefit for cardiac and brain imaging, where MRI is the predominant modality. In this article, we aimed to summarize and basic review of potential clinical applications and technical features of PET/MRI.